Research ID |
Investigator Name |
Research Topic |
Research Status |
1 | Panu | Disease Progression of Type 2 Diabetes Mellitus: A cohort profile | MS submitted |
2 | Panu | Prediction of diabetic retinopathy in type 2 diabetes: Time-varying Cox and machine learning models | MS submitted |
3 | Teerapat | Treatment effectiveness of second-line drugs in prevention of HF | On going |
4 | Teerapat | Prognostic factors of HF in T2D | MS submitted |
5 | Sukanya | Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes | Published |
6 | Sukanya | Emulation of a target trial assessing the effectiveness of second-line anti-diabetic drugs on major adverse cardiovascular events | Published |
7 | Thitiya | Effect of second-line drugs on diabetic ratinopathy | On going |
8 | Thunyarat | Effect of second-line drugs on fatty liver (NAFLD/NASH) | On going |
10 | Montarat | Cost-Utility Analysis of Laparoscopic Bariatric Surgery for Obesity with type II Diabetes Mellitus | On going |
11 | Surakiat | Effects of second-line drugs in lowering PAD occurrence | For graduation |
12 | Surakiat | Hypoglycemic events and economic evaluation in treatment managements of T2D patients | For graduation |
13 | Thunyarat | Short and Long term outcomes between patients who are treated in DM clinic vs non-DM clinic | For graduation |
14 | Ammarin | Association of statin therapy initiation with diabetes progression (TE+mediation) | Suspend |
15 | Ammarin | T2D real-world medications use | Suspend |
16 | Ammarin | Effect of second-line drugs on fractures (feasibility checking)
(NMA feasibliity checking by Thitiya) | Suspend |
17 | Sukanya | Cucurmin supplement and glycemic control | Suspend |
18 | Sukanya | Counterfactual prognostic model under hypothetical treatment of SGLT2i in type 2 diabetes | Suspend |
34 | Oraluck | Cost-Effectiveness of Second-line Drugs for Improved Glycaemic Control for Type 2 Diabetes Mellitus in Thailand | On going |
49 | Amarit | Effects of second-line antihyperglycemic medications on chronic kidney disease progression: A multistate analysis | MS submitted |